Americans Who Received J&J Jab More Likely To Develop Rare Blood Clots, New Mayo Clinic Study Finds
Francesco Abbruzzino, The Uncensored Report, LLC
It’s starting to seem like nary a day goes by that the world doesn’t isn’t confronted with new research raising safety questions about either the mRNA vaccines (mostly Moderna) or the adenovirus-vector jabs like the AstraZeneca and J&J jabs.
On Monday, the bad news focused on the adenovirus jabs, particularly the J&J jab, as researchers from the Mayo Clinic in Rochester Minnesota, who published their findings in JAMA Internal Medicine, compared data from the general population before the pandemic to data gathered from reported vaccine side effects suffered by Americans.
What they found was disturbing: a person who received the vaccine was 3.5x as likely to develop brain blood clots as an average person before the pandemic.
Blood clots, and specifically cerebral venous sinus thrombosis are well known side-effects of the J&J vaccine, and the discovery of this risk was the reason usage of the vaccine was paused in April. Still, however, the team insists the side-effect is rare and that the findings must be looked at in the context of the effectiveness of the vaccine in preventing severe cases COVID-19.